Heart Transplant clinical trials at UCSD
2 in progress, 1 open to eligible people
open to eligible people ages 18 years and up
The investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular and macroscopic causes.
La Jolla, California
Sorry, not currently recruiting here
The purpose of this research study is to see if a study drug called Tocilizumab will, when given with standard anti-rejection medicines, lead to better heart transplantation outcomes at 1 year after the transplant. Specifically, the investigators will evaluate whether taking tocilizumab leads to less rejection, less development of unwanted antibodies, and better heart function.
La Jolla, California and other locations